107 related articles for article (PubMed ID: 30196539)
1. Neutrophil to lymphocyte ratio is an independent predictor of outcome for patients undergoing definitive resection for stage IV melanoma.
Kanatsios S; Melanoma Project M; Li Wai Suen CSN; Cebon JS; Gyorki DE
J Surg Oncol; 2018 Nov; 118(6):915-921. PubMed ID: 30196539
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
[TBL] [Abstract][Full Text] [Related]
3. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract][Full Text] [Related]
4. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.
Rochet NM; Kottschade LA; Grotz TE; Porrata LF; Markovic SN
Am J Clin Oncol; 2015 Jun; 38(3):252-8. PubMed ID: 23774073
[TBL] [Abstract][Full Text] [Related]
6. Metastasectomy for recurrent stage IV melanoma.
Ollila DW; Hsueh EC; Stern SL; Morton DL
J Surg Oncol; 1999 Aug; 71(4):209-13. PubMed ID: 10440757
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy.
Zhang GM; Zhu Y; Gu WJ; Zhang HL; Shi GH; Ye DW
Int J Clin Oncol; 2016 Apr; 21(2):373-378. PubMed ID: 26335242
[TBL] [Abstract][Full Text] [Related]
8. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
[TBL] [Abstract][Full Text] [Related]
9. Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer.
Li H; Song J; Cao M; Wang G; Li L; Zhang B; Li Y; Xu W; Zheng J
Int Immunopharmacol; 2016 Nov; 40():327-331. PubMed ID: 27664571
[TBL] [Abstract][Full Text] [Related]
10. Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.
Davis JL; Langan RC; Panageas KS; Zheng J; Postow MA; Brady MS; Ariyan C; Coit DG
Ann Surg Oncol; 2017 Jul; 24(7):1989-1996. PubMed ID: 28303429
[TBL] [Abstract][Full Text] [Related]
11. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
[TBL] [Abstract][Full Text] [Related]
12. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
Kao SC; Klebe S; Henderson DW; Reid G; Chatfield M; Armstrong NJ; Yan TD; Vardy J; Clarke S; van Zandwijk N; McCaughan B
J Thorac Oncol; 2011 Nov; 6(11):1923-9. PubMed ID: 22011651
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies.
Spolverato G; Maqsood H; Kim Y; Margonis G; Luo T; Ejaz A; Pawlik TM
J Surg Oncol; 2015 Jun; 111(7):868-74. PubMed ID: 25865111
[TBL] [Abstract][Full Text] [Related]
14. Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma.
Lino-Silva LS; Salcedo-Hernández RA; García-Pérez L; Meneses-García A; Zepeda-Najar C
Melanoma Res; 2017 Apr; 27(2):140-144. PubMed ID: 28125448
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
16. Platelet-to-lymphocyte ratio in peripheral blood: A novel independent prognostic factor in patients with melanoma.
Qi Y; Zhang Y; Fu X; Wang A; Yang Y; Shang Y; Gao Q
Int Immunopharmacol; 2018 Mar; 56():143-147. PubMed ID: 29414644
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary metastasectomy for malignant melanoma: prognostic factors for long-term survival.
Younes R; Abrao FC; Gross J
Melanoma Res; 2013 Aug; 23(4):307-11. PubMed ID: 23787816
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of melanoma lung metastasis: an analysis of survival outcomes in 292 consecutive patients.
Chua TC; Scolyer RA; Kennedy CW; Yan TD; McCaughan BC; Thompson JF
Ann Surg Oncol; 2012 Jun; 19(6):1774-81. PubMed ID: 22290565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]